NYSEAMERICAN:DXR - Daxor Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $12.26 -0.22 (-1.76 %) (As of 03/25/2019 04:00 PM ET)Previous Close$12.48Today's Range$11.90 - $12.3552-Week Range$4.30 - $19.95Volume11,725 shsAverage Volume62,027 shsMarket Capitalization$45.72 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Daxor Corporation, a medical device company, provides biotechnology and cryobanking services in the United States. The company offers BVA-100 Blood Volume Analyzer, an instrument that measures blood volume in human body. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients in various medical and surgical conditions, including congestive heart failure, critical care medicine and intensive care unit medicine, hypertension, syncope, pre-operative blood screening for hidden anemia, anemia in cancer patients, kidney failure, and hyponatremia. It also provides semen banking, blood storage, andrology, and general lab testing services. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York. Receive DXR News and Ratings via Email Sign-up to receive the latest news and ratings for DXR and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSEAMERICAN Industry Medical Instruments & Supplies Sub-IndustryN/A SectorMedical Current SymbolNYSEAMERICAN:DXR Previous SymbolNYSE:DXR CUSIPN/A CIK27367 Webwww.daxor.com Phone+1-212-3308500Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares3,729,000Market Cap$45.72 million Next Earnings DateN/A OptionableNot Optionable Daxor (NYSEAMERICAN:DXR) Frequently Asked Questions What is Daxor's stock symbol? Daxor trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "DXR." Has Daxor been receiving favorable news coverage? News articles about DXR stock have trended positive this week, InfoTrie Sentiment reports. The research firm ranks the sentiment of press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Daxor earned a media sentiment score of 2.3 on InfoTrie's scale. They also gave news articles about the company a news buzz of 7.0 out of 10, indicating that recent press coverage is likely to have an effect on the stock's share price in the near term. Are investors shorting Daxor? Daxor saw a decline in short interest during the month of February. As of February 28th, there was short interest totalling 236,283 shares, a decline of 8.7% from the February 15th total of 258,809 shares. Based on an average daily trading volume, of 29,158 shares, the days-to-cover ratio is presently 8.1 days. Approximately 30.1% of the shares of the stock are sold short. View Daxor's Current Options Chain. Who are some of Daxor's key competitors? Some companies that are related to Daxor include Tristel (TSTL), SDI (SDI), InfuSystem (INFU), TSO3 (TOS), Retractable Technologies (RVP), IsoRay (ISR), IsoRay (ISR), Omega Diagnostics Group (ODX), Milestone Scientific (MLSS), Relevium Technologies (RLV), Impression Healthcare (IHL), Vigil Health Solutions (VGL), Akers Biosciences (AKR), ANSELL LTD/S (ANSLY) and CONVATEC GRP PL/ADR (CNVVY). What other stocks do shareholders of Daxor own? Based on aggregate information from My MarketBeat watchlists, some companies that other Daxor investors own include Coherus Biosciences (CHRS), Rigel Pharmaceuticals (RIGL), Pfenex (PFNX), Protalix Biotherapeutics (PLX), Fate Therapeutics (FATE), Oragenics (OGEN), Zafgen (ZFGN), Heat Biologics (HTBX), Palatin Technologies (PTN) and Lipocine (LPCN). Who are Daxor's key executives? Daxor's management team includes the folowing people: Mr. Michael Richard Feldschuh, Chairman, Pres & CEO (Age 50)Mr. Jonathan Adam Feldschuh, Chief Scientific Officer & Director (Age 54)Mr. Robert J. Michel CPA, Chief Financial Officer (Age 62)Ms. Kathryn A. Kornafel, VP of Marketing & Commercial Devel.Mr. Guido Manzo, VP of Sales How do I buy shares of Daxor? Shares of DXR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Daxor's stock price today? One share of DXR stock can currently be purchased for approximately $12.26. How big of a company is Daxor? Daxor has a market capitalization of $45.72 million. What is Daxor's official website? The official website for Daxor is http://www.daxor.com/. How can I contact Daxor? Daxor's mailing address is 350 5th Ave Ste 4740, NEW YORK, NY 10118-0002, United States. The company can be reached via phone at +1-212-3308500. MarketBeat Community Rating for Daxor (NYSEAMERICAN DXR)Community Ranking: 2.7 out of 5 ( )Outperform Votes: 99 (Vote Outperform)Underperform Votes: 86 (Vote Underperform)Total Votes: 185MarketBeat's community ratings are surveys of what our community members think about Daxor and other stocks. Vote "Outperform" if you believe DXR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DXR will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/25/2019 by MarketBeat.com StaffFeatured Article: What is the Bid-Ask Spread?